Skip to main content
FogPharma Logo
  • About
  • Science
  • Pipeline
  • Culture & Careers
  • News
Back

FogPharma® Announces $107 Million Series C Financing to Advance Direct β-Catenin Antagonist and Universal Druggability™ Platform

03/01/2021

Read more https://www.businesswire.com/news/home/20210301005266/en/FogPharma%C2%AE-Announces-107-Million-Series-C-Financing-to-Advance-Direct-%CE%B2-Catenin-Antagonist-and-Universal-Druggability%E2%84%A2-Platform

FogPharma Logo
LinkedIn
Contact Us
  • Privacy Policy
  • Terms & Conditions

2023© FogPharma